| __timestamp | Celldex Therapeutics, Inc. | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 101881000 | 56369000000 |
| Thursday, January 1, 2015 | 4011000 | 62786000000 |
| Friday, January 1, 2016 | 102026000 | 62427000000 |
| Sunday, January 1, 2017 | 96171000 | 62453000000 |
| Monday, January 1, 2018 | 66449000 | 65724000000 |
| Tuesday, January 1, 2019 | 42672000 | 70421000000 |
| Wednesday, January 1, 2020 | 42534000 | 80591000000 |
| Friday, January 1, 2021 | 3068000 | 86645000000 |
| Saturday, January 1, 2022 | 1400000 | 100551000000 |
| Sunday, January 1, 2023 | 3008000 | 42907000000 |
| Monday, January 1, 2024 | 115557000000 |
Cracking the code
In the competitive landscape of pharmaceuticals, cost efficiency is paramount. Dr. Reddy's Laboratories Limited and Celldex Therapeutics, Inc. offer a fascinating study in contrasts. Over the past decade, Dr. Reddy's has consistently maintained a robust cost of revenue, peaking at approximately 115% of its 2014 value by 2024. This reflects a steady growth trajectory, underscoring its operational efficiency and market resilience.
Conversely, Celldex Therapeutics has experienced a more volatile journey. From a high in 2014, its cost of revenue plummeted by over 97% by 2022, indicating strategic shifts or market challenges. The absence of data for 2024 suggests potential restructuring or data reporting changes.
This comparison highlights the diverse strategies within the pharmaceutical sector, where scale and agility can dictate financial outcomes. As the industry evolves, these insights offer a glimpse into the financial health and strategic direction of key players.
Cost of Revenue: Key Insights for Novo Nordisk A/S and Dr. Reddy's Laboratories Limited
Cost of Revenue Comparison: Novo Nordisk A/S vs Celldex Therapeutics, Inc.
Cost of Revenue Comparison: Johnson & Johnson vs Dr. Reddy's Laboratories Limited
Comparing Cost of Revenue Efficiency: GSK plc vs Dr. Reddy's Laboratories Limited
Comparing Cost of Revenue Efficiency: GSK plc vs Celldex Therapeutics, Inc.
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Bio-Techne Corporation
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs PTC Therapeutics, Inc.
Dr. Reddy's Laboratories Limited and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
Sarepta Therapeutics, Inc. vs Celldex Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Walgreens Boots Alliance, Inc. vs Celldex Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Cytokinetics, Incorporated and Celldex Therapeutics, Inc.
Analyzing Cost of Revenue: Ligand Pharmaceuticals Incorporated and Celldex Therapeutics, Inc.